title: The liver transplant waiting list--a single-center analysis.
abstract: At this transplant center 1340 patients were entered on the liver transplant waiting list during the first 25 months (October 1987 to November 1989) after the initiation of the UNOS allocation system for liver grafts. Of these 972 (72.5%) of the patients received a graft, 120 (9.0%) died waiting for a graft, 109 (8.1%) remained on the active list as of the study endpoint of December 15, 1989, 123 (9.2%) were withdrawn from candidacy, and 16 (1.2%) received a transplant at another center. A total of 1201 patients were candidates for a first graft. Of the 812 primary candidates who received a graft, 64.8% received their graft within one month of entry on the waiting list. Of the 109 primary candidates who died before a graft could be found, 79.0% died within a month of entry onto the waiting list. At time of transplantation, 135 (16.6%) primary recipients of a graft were UNOS class 1, 326 (40.1%) were UNOS class 2, 190 (23.4%) were UNOS class 3, and 161 (19.8%) were UNOS class 4. Actuarial survival rates (percentage) at 6 months for recipients in UNOS class 1, class 2, class 3, and class 4 were 88.7 +/- 2.9, 82.6 +/- 2.1, 78.4 +/- 3.2, and 68.4 +/- 3.9, respectively (P less than 0.001). At the time of death of recipients who failed to get a graft, 6 (5.5%) were UNOS class 1, 14 (12.8%) were UNOS class 2, 23 (21.1%) were UNOS class 3, and 66 (60.6%) were UNOS class 4. These results indicate that a high proportion of liver transplant candidates are in urgent need of a graft and that the UNOS system succeeds in giving these patients high priority. However patient mortality on the waiting list and after transplantation would lessen significantly if more patients with end-stage liver disease were referred to the transplant center in a timely manner before their condition reaches the point where the probability of survival is diminished.
authors.affiliation: Department of Surgery, University of Pittsburgh School of Medicine, Pennsylvania.
authors.forename: R D
authors.initials: RD
authors.lastname: Gordon
authors.forename: C M
authors.initials: CM
authors.lastname: Hartner
authors.forename: A
authors.initials: A
authors.lastname: Casavilla
authors.forename: R R
authors.initials: RR
authors.lastname: Selby
authors.forename: O
authors.initials: O
authors.lastname: Bronsther
authors.forename: L
authors.initials: L
authors.lastname: Mieles
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: A G
authors.initials: AG
authors.lastname: Tzakis
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000017:ABO Blood-Group System; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008107:Liver Diseases / Q000601:surgery; D016031:Liver Transplantation / Q000401:mortality / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D010414:Pennsylvania; D012086:Reoperation; D015996:Survival Rate; D013997:Time Factors; D009927:Tissue and Organ Procurement; D014850:Waiting Lists
chemical_list: D000017:ABO Blood-Group System